Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
Tumor recognition by immune effector cells is mediated by antigen receptors and a variety of adhesion and costimulatory molecules. The evidence accumulated since the identification of CD155 and CD112 as ligands for DNAM-1 in humans and mice has suggested that the interactions between DNAM-1 and its...
Main Authors: | Yoko Nagumo, Akiko Iguchi-Manaka, Yumi Yamashita-Kanemaru, Fumie Abe, Günter Bernhardt, Akira Shibuya, Kazuko Shibuya |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4226556?pdf=render |
Similar Items
-
Increased Soluble CD155 in the Serum of Cancer Patients.
by: Akiko Iguchi-Manaka, et al.
Published: (2016-01-01) -
Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4+ T cell costimulation
by: Eri Takenaka, et al.
Published: (2018-10-01) -
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
by: Taofei Zeng, et al.
Published: (2021-09-01) -
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
by: Amelia Roman Aguilera, et al.
Published: (2018-05-01) -
CD112 Regulates Angiogenesis and T Cell Entry into the Spleen
by: Erica Russo, et al.
Published: (2021-01-01)